These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36143233)

  • 1. Downstream Alternate Start Site Allows N-Terminal Nonsense Variants to Escape NMD and Results in Functional Recovery by Readthrough and Modulator Combination.
    Bowling A; Eastman A; Merlo C; Lin G; West N; Patel S; Cutting G; Sharma N
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.
    Mutyam V; Sharma J; Li Y; Peng N; Chen J; Tang LP; Falk Libby E; Singh AK; Conrath K; Rowe SM
    Am J Respir Cell Mol Biol; 2021 May; 64(5):604-616. PubMed ID: 33616476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators.
    Chen J; Thrasher K; Fu L; Wang W; Aghamohammadzadeh S; Wen H; Tang L; Keeling KM; Falk Libby E; Bedwell DM; Rowe SM
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L756-L770. PubMed ID: 37014818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Readthrough-induced misincorporated amino acid ratios guide mutant-specific therapeutic approaches for two CFTR nonsense mutations.
    Premchandar A; Ming R; Baiad A; Da Fonte DF; Xu H; Faubert D; Veit G; Lukacs GL
    Front Pharmacol; 2024; 15():1389586. PubMed ID: 38725656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capitalizing on the heterogeneous effects of CFTR nonsense and frameshift variants to inform therapeutic strategy for cystic fibrosis.
    Sharma N; Evans TA; Pellicore MJ; Davis E; Aksit MA; McCague AF; Joynt AT; Lu Z; Han ST; Anzmann AF; Lam AN; Thaxton A; West N; Merlo C; Gottschalk LB; Raraigh KS; Sosnay PR; Cotton CU; Cutting GR
    PLoS Genet; 2018 Nov; 14(11):e1007723. PubMed ID: 30444886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations.
    McHugh DR; Cotton CU; Hodges CA
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis.
    Clarke LA; Luz VCC; Targowski S; Ramalho SS; Farinha CM; Amaral MD
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.
    de Poel E; Spelier S; Suen SWF; Kruisselbrink E; Graeber SY; Mall MA; Weersink EJM; van der Eerden MM; Koppelman GH; van der Ent CK; Beekman JM
    J Cyst Fibros; 2022 Mar; 21(2):246-253. PubMed ID: 34666947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsense-mediated mRNA decay and cystic fibrosis.
    Linde L; Kerem B
    Methods Mol Biol; 2011; 741():137-54. PubMed ID: 21594783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
    Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
    J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine boosts Ataluren's readthrough activity.
    Lentini L; Melfi R; Cancemi P; Pibiri I; Di Leonardo A
    Heliyon; 2019 Jun; 5(6):e01963. PubMed ID: 31294114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.
    Sharma J; Du M; Wong E; Mutyam V; Li Y; Chen J; Wangen J; Thrasher K; Fu L; Peng N; Tang L; Liu K; Mathew B; Bostwick RJ; Augelli-Szafran CE; Bihler H; Liang F; Mahiou J; Saltz J; Rab A; Hong J; Sorscher EJ; Mendenhall EM; Coppola CJ; Keeling KM; Green R; Mense M; Suto MJ; Rowe SM; Bedwell DM
    Nat Commun; 2021 Jul; 12(1):4358. PubMed ID: 34272367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway.
    Sanderlin EJ; Keenan MM; Mense M; Revenko AS; Monia BP; Guo S; Huang L
    Nat Commun; 2022 Apr; 13(1):2344. PubMed ID: 35487895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTR.
    Karri S; Cornu D; Serot C; Biri L; Hatton A; Dréanot E; Rullaud C; Pranke I; Sermet-Gaudelus I; Hinzpeter A; Bidou L; Namy O
    J Cyst Fibros; 2024 Nov; 23(6):1185-1194. PubMed ID: 39098506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
    Venturini A; Borrelli A; Musante I; Scudieri P; Capurro V; Renda M; Pedemonte N; Galietta LJV
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR.
    Yeh JT; Hwang TC
    J Physiol; 2020 Feb; 598(3):517-541. PubMed ID: 31585024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
    Clarke LA; Awatade NT; Felício VM; Silva IA; Calucho M; Pereira L; Azevedo P; Cavaco J; Barreto C; Bertuzzo C; Gartner S; Beekman J; Amaral MD
    Hum Mutat; 2019 Mar; 40(3):326-334. PubMed ID: 30488522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased mRNA and protein stability of W1282X limits response to modulator therapy.
    Aksit MA; Bowling AD; Evans TA; Joynt AT; Osorio D; Patel S; West N; Merlo C; Sosnay PR; Cutting GR; Sharma N
    J Cyst Fibros; 2019 Sep; 18(5):606-613. PubMed ID: 30803905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
    Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
    Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough.
    Lee RE; Lewis CA; He L; Bulik-Sullivan EC; Gallant SC; Mascenik TM; Dang H; Cholon DM; Gentzsch M; Morton LC; Minges JT; Theile JW; Castle NA; Knowles MR; Kimple AJ; Randell SH
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.